EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Exploring the Potential of Non-Viral Nanocarriers for Improving Blood-Brain Barrier Permeability to Enhance the Treatment of Brain Diseases

Zijie Yu iD, Zhihong Sun, Lu Yuan, Cuicui Wang, Wei Li, Jie Liu, Qi Zhao, Yong Sun iD, Chengming Sun

International Journal of Nanomedicine · 2025-10 · Volume 20 · 12593-12625

DOI: 10.2147/ijn.s545696 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2025-10. Verfasst von Zijie Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Qingdao Medical College, Qingdao University, Qingdao, Shandong, People's Republic of China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Brain Diseases, Nanoparticles, Drug Carriers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain diseases have become an important health problem worldwide, especially in the aging population, and their incidence and prevalence continue to increase. Despite remarkable progress in medical technology, the treatment of brain diseases still faces many challenges, especially limitations caused by the blood-brain barrier (BBB), which significantly hinders the delivery of therapeutic drugs to the brain. In recent years, non-viral nanocarriers developed by nanotechnology have shown great potential for crossing the BBB, and have attracted much attention due to their low immunogenicity, high biocompatibility and good targeting. In this paper, we review the basic structure of the BBB, properties of nonviral vectors, and the mechanisms of crossing BBB. Moreover, this review summarizes the main types of non-viral vectors-liposomes, polymeric nanoparticles, biomimetic materials, and inorganic nanomaterials-while addressing the main translational barriers, including low BBB permeability, poor systemic stability, nonspecific peripheral accumulation, manufacturing challenges, and limited clinical validation, and suggests future research directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierBrain DiseasesNanoparticlesDrug CarriersHumansAnimalsPermeabilityLiposomesDrug Delivery Systems

Stichwörter der Autor:innen

blood-brain barrierbrain diseasesbrain drug deliverynon-viral nanocarriers

Substanzen

Drug CarriersLiposomes

Autor:innen und Institutionen

  • Department of Pharmaceutics, School of Pharmacy, Qingdao Medical College, Qingdao University, Qingdao, Shandong, People's Republic of China.
  • The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, People's Republic of China.

ORCID-Profile: Zijie Yu, Yong Sun

Zitieren

APA

Yu, Z., Sun, Z., Yuan, L., Wang, C., Li, W., Liu, J., Zhao, Q., Sun, Y., & Sun, C. (2025). Exploring the Potential of Non-Viral Nanocarriers for Improving Blood-Brain Barrier Permeability to Enhance the Treatment of Brain Diseases. International Journal of Nanomedicine, Volume 20, 12593-12625. https://doi.org/10.2147/ijn.s545696

Vancouver

Yu Z, Sun Z, Yuan L, Wang C, Li W, Liu J, et al. Exploring the Potential of Non-Viral Nanocarriers for Improving Blood-Brain Barrier Permeability to Enhance the Treatment of Brain Diseases. International Journal of Nanomedicine. 2025;Volume 20:12593-12625. doi:10.2147/ijn.s545696

BibTeX
@article{Yu2025,
  author = {Yu, Zijie and Sun, Zhihong and Yuan, Lu and Wang, Cuicui and Li, Wei and Liu, Jie and Zhao, Qi and Sun, Yong and Sun, Chengming},
  title = {Exploring the Potential of Non-Viral Nanocarriers for Improving Blood-Brain Barrier Permeability to Enhance the Treatment of Brain Diseases},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  volume = {Volume 20},
  pages = {12593--12625},
  doi = {10.2147/ijn.s545696}
}
Kostenlos starten →